Milkovich G
Alexandria Hospital, VA.
Hosp Pract (Off Ed). 1993 Jun;28 Suppl 1:39-43. doi: 10.1080/21548331.1993.11442934.
The costs of outpatient parenteral antibiotic therapy are outweighed by the benefits to all involved: provider, payer, patient, and society. Simple comparisons of inpatient and outpatient charges are not a true measure of costs. Recent in-depth cost-benefit analyses reveal a significant saving when indirect benefits, such as increased productivity and quality of life, are included. Even so, financial issues remain to be addressed.
门诊胃肠外抗生素治疗的成本与给所有相关方（医疗服务提供者、付款方、患者和社会）带来的益处相比是值得的。简单比较住院和门诊费用并非对成本的真实衡量。最近深入的成本效益分析表明，若将诸如提高生产力和生活质量等间接益处纳入考量，会有显著的节省。即便如此，财务问题仍有待解决。
